Treatment costs in hodgkin's disease: A cost-utility analysis
- 1 August 1996
- journal article
- research article
- Published by Elsevier in European Journal Of Cancer
- Vol. 32 (9) , 1510-1517
- https://doi.org/10.1016/0959-8049(96)00142-6
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Treatment of Hodgkin's disease in a small oncological unitEuropean Journal of Haematology, 2009
- Psychological distress in survivors of Hodgkin's diseaseSupportive Care in Cancer, 1996
- The Ch1VPP regimen, a risk factor for herpes zoster virus infection in patients treated for Hodgkin's diseaseEuropean Journal of Haematology, 1994
- PRODUCTION GAINS: SHOULD THEY COUNT IN HEALTH CARE EVALUATIONS?Scottish Journal of Political Economy, 1994
- Towards a new approach for estimating indirect costs of diseaseSocial Science & Medicine, 1992
- The optimal timing of autologous bone marrow transplantation in Hodgkin's disease patients after a chemotherapy relapse.Journal of Clinical Oncology, 1992
- EuroQol - a new facility for the measurement of health-related quality of lifeHealth Policy, 1990
- Twenty years of MOPP therapy for Hodgkin's disease.Journal of Clinical Oncology, 1986
- Curability of Advanced Hodgkin's Disease with ChemotherapyAnnals of Internal Medicine, 1980
- Foundations of Cost-Effectiveness Analysis for Health and Medical PracticesNew England Journal of Medicine, 1977